Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01996306 |
|---|---|
| Brief Title: | A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC (AXEPT) |
| First Submitted : | November 22, 2013 |
| First Submitted that Met QC Criteria : | November 22, 2013 |
| First Posted : | November 27, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 6, 2019 |
| Last Update Posted : | January 8, 2019 |